 2. Progression while on or following completion of Letrozole or Anastrozole treatment for ABCMBC. Note: Non-steroidal aromatase inhibitors i.e. Letrozole or Anastrozole do not have to be the last treatment prior to enrollment. Other prior anticancer therapy, e.g. Tamoxifen, Fulvestrant, Exemestane, is also allowed. Patients must have recovered to grade 1 or better from any adverse events except alopecia related to previous therapy prior to enrollment. 